State KY
Clinical Trials in Kentucky
Recruiting clinical trials with at least one study location in Kentucky. Data updated daily from ClinicalTrials.gov.
Top Conditions in Kentucky
Frequently Asked Questions — Clinical Trials in Kentucky
How many clinical trials are currently recruiting in Kentucky?
ClinicalMetric currently tracks 133 actively recruiting clinical trials with at least one location in Kentucky. The total number of registered studies—including active but not currently enrolling trials—is 133. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kentucky?
Kentucky hosts clinical trials across a broad range of medical conditions, including Non-small Cell Lung Cancer, Type 2 Diabetes, Heart Failure, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kentucky serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kentucky?
To join a clinical trial in Kentucky, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kentucky maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Kentucky
NCT05929768 Phase 3
Recruiting
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple N...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
2,400 pts
Location
United States, Mexico, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT06154447 Phase 1
Recruiting
Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fib...
Condition
Cystic Fibrosis
Enrollment
255 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT06346392 Phase 3
Recruiting
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Seco...
Condition
Gastric Cancer
Enrollment
572 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
NCT04005976 N/A
Recruiting
Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic D...
Condition
Aortic Aneurysm
Enrollment
5,000 pts
Location
United States, Australia, Belgium
Sponsor
The University of Texas Health
NCT07188376 N/A
Recruiting
Mitigating the Disinhibiting Effects of Alcohol With Transcranial Magnetic Stimu...
Condition
Alcohol Risk Behaviors
Enrollment
12 pts
Location
United States
Sponsor
Michael J. Wesley, PhD
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
NCT06952660 Phase 4
Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic C...
Condition
Cervical Cancer
Enrollment
100 pts
Location
United States, Puerto Rico
Sponsor
Pfizer
NCT06498960 N/A
Recruiting
Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in No...
Condition
Normal Pressure Hydrocephalus
Enrollment
230 pts
Location
United States, Argentina, Canada
Sponsor
CereVasc Inc
NCT04994756 N/A
Recruiting
Stroke Thrombectomy and Aneurysm Registry
Condition
Stroke
Enrollment
40,000 pts
Location
United States, Canada, Germany
Sponsor
Medical University of South Ca
NCT07092865 Phase 2
Recruiting
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respirat...
Condition
Respiratory Syncytial Virus Infections
Enrollment
184 pts
Location
United States, Australia, Canada
Sponsor
GlaxoSmithKline
NCT07318207 N/A
Recruiting
Time-restricted Eating for Patients With Type 2 Diabetes
Condition
Type 2 Diabetes
Enrollment
102 pts
Location
United States
Sponsor
Justin (Matt) Thomas
NCT05064709 N/A
Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Condition
Heart Failure
Enrollment
1,500 pts
Location
United States
Sponsor
Impulse Dynamics
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT04969315 Phase 1, Phase 2
Recruiting
TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects...
Condition
Renal Cell Cancer
Enrollment
90 pts
Location
United States
Sponsor
Portage Biotech
NCT04715178 N/A
Recruiting
Beat Childhood Cancer Specimen Banking and Data Registry
Condition
Pediatric Cancer
Enrollment
1,000 pts
Location
United States
Sponsor
Giselle Sholler
NCT05183035 Phase 3
Recruiting
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Condition
Acute Myeloid Leukemia
Enrollment
130 pts
Location
United States, Australia, Austria
Sponsor
PedAL BCU, LLC
NCT05034432 Phase 4
Recruiting
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventri...
Condition
Arrythmia
Enrollment
100 pts
Location
United States
Sponsor
University of Rochester
NCT04637763 Phase 1
Recruiting
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B ...
Condition
Lymphoma, Non-Hodgkin
Enrollment
72 pts
Location
United States, Australia, Israel
Sponsor
Caribou Biosciences, Inc.
NCT04990921 Phase 2
Recruiting
Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metast...
Condition
Metastatic Breast Cancer
Enrollment
15 pts
Location
United States
Sponsor
University of Louisville
NCT06911502 Phase 3
Recruiting
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Ri...
Condition
Follicular Lymphoma
Enrollment
400 pts
Location
United States, Australia, Brazil
Sponsor
Celgene
NCT05940857 N/A
Recruiting
US National OCS Liver Perfusion (OLP) Registry
Condition
Liver Transplant
Enrollment
100,000 pts
Location
United States
Sponsor
TransMedics
NCT05828511 Phase 1, Phase 2
Recruiting
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerat...
Condition
Multiple Myeloma
Enrollment
149 pts
Location
United States, France, Spain
Sponsor
Regeneron Pharmaceuticals
NCT05863195 Phase 3
Recruiting
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus St...
Condition
Metastatic Colorectal Carcinoma
Enrollment
408 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT04329728 Phase 1, Phase 2
Recruiting
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Condition
Lymphoid Malignancies
Enrollment
144 pts
Location
United States
Sponsor
AVM Biotechnology Inc
NCT03998202 N/A
Recruiting
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal...
Condition
Colorectal Cancer
Enrollment
300 pts
Location
United States
Sponsor
Wake Forest University Health
Page 1 of 6 — 133 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology